Serum antibodies to the cornea were investigated in patients with peripheral ulcerative keratitis (PUK) in iso lation or in association with a systemic disease (rheu matoid arthritis or Wegener's granulomatosis). Indirect immunofluorescence on bovine corneal sections demon strated that antibodies bound to epithelial antigens in two distinct patterns: a lattice-like pattern, probably staining intercellular membrane antigens, and a diffuse pattern covering the entire surface of the epithelium. Both pat terns were associated with PUK rather than systemic disease whilst the presence of the lattice pattern was more associated with the onset of the PUK. Immunoblotting of sera to corneal epithelial protein extracts demonstrated that a number of corneal antigens were targeted by anti bodies. 1\vo antigens, 54 kDa and 70 kDa, were of par ticular interest. Antibodies to the 54 kDa antigen, the major corneal-specific antigen, were also detected by enzyme-linked immunosorbent assay (ELISA). Longi tudinal studies showed that these antibodies often first occurred after an episode of PUK. Antibodies to the 70 kDa antigen were related to the Wegener's granu lomatosis rather than the PUK.
Peripheral ulcerative keratitis (PUK) or corneal melt is a rare but sight-threatening condition which may occur either in isolation or in association with a systemic disease, which is usually an immunologically mediated disorder.l-4 The pathogenesis of PUK remains poorly understood but there is evidence for an autoimmune aetiology both in this condition and in other types of per ipheral corneal destructive disease. Circulating antibodies to both corneal and conjunctival epithelium have been Eye (1992) 6, [630] [631] [632] [633] [634] [635] [636] detected in the serum from patients with peripheral cor neal destructive disease.5-s Plasma cell infiltrates, immu noglobulins and complement deposits have been found in the conjunctiva adjacent to the diseased tissue.5.s Cell mediated immunity to corneal antigens has also been reported in patients with corneal diseaselO•11 and in those who have undergone corneal transplantation.12 •13 Both humoral and cellular immunity to a specific cor neal antigen, the 54 kDa protein of the bovine cornea (BSP54), have been demonstrated in patients with periph eral corneal destructive disease.14 This protein, which is present in all layers, constitutes approximately 30% of the soluble proteins of the cornea. 15 Immunologically similar proteins exist in other species including humans. 1 6 In patients with both PUK and systemic disease, anti bodies to components of non-corneal tissue may cross react with corneal antigens and thus contribute to the development of the corneal disease. Alternatively anti bodies specific to the cornea may be produced as a result of exposure of corneal-specific antigens to the immune system. It is possible that these antibodies could be involved in the induction of PUK or play a role in disease progression. To investigate these alternatives, we have examined sera from different groups of patients for the presence of antibodies to corneal antigens. The patient groups include patients with PUK in isolation, patients with PUK in association with either Wegener's granu lomatosis (WG) or rheumatoid arthritis (RA), and patients with systemic disease but no detectable ocular symptoms.
MATERIALS AND METHODS

Patients
Blood was taken from patients attending the Manchester Royal Eye Hospital or the Rheumatology Department of Manchester Royal Infirmary.
The diagnosis, sex, mean age and age range of the patients are summarised in Table I. The diagnosis of rheu  matoid arthritis and Wegener's granulomatosis was made  according to the ARA criteria.17,18 Blood was collected, allowed to clot at room temperature, and then centrifuged at 1500 g for 10 minutes. The serum was removed and stored in aliquots at -20°C until required. Sera from normal, healthy blood donors were also included as controls.
Detection of Antibodies to Corneal Antigens by Immunofluorescence
Sera were tested for antibodies to the cornea by an indirect immunofluorescence technique. Fresh bovine corneas, obtained from the abattoir, were snap frozen in liquid nitrogen. Sections (5 11m) were cut in a cryostat, air dried onto 3-(triethoxysilyl)-propylamine-coated glass slides and fixed in acetone for 5 minutes. After washing in phos phate-buffered saline (PBS, pH 7.5) the sections were incubated with patients' or control sera, diluted 1 : 20 in PBS, for 30 minutes at room temperature. After washing, the slides were incubated with fluorescein isothiocyanate (FITC)-conjugated secondary antibody diluted 1 : 40 in PBS, at room temperature for 30 minutes. The secondary antibodies used were either rabbit anti-human IgGAM, or anti-human IgG, or IgA, or IgM (DAKO Ltd). The slides were washed again in PBS and the sections mounted in glycerol/PBS (9 : 1). The slides were examined using a Vickers photoplan microscope at 490 nm wavelength. Some sera were also tested on rat or human corneal sec tions which were frozen and prepared in the same way as the bovine cornea. Sera were also tested, by the above technique, using frozen sections of bovine skin, oesopha gus or intestine as substrate.
Preparation of Soluble Corneal Epithelial Extract
Corneal epithelium was removed from fresh bovine eyes. A scalpel blade was used to scrape off the epithelium from the central region of the cornea ensuring no tissue from the limbal region was included. Three hundred milligrams of tissue was homogenised in 5 ml of 0.1 mol/l NaCI, 40 mmol/l TrislHCI pH 7. 8. The homogenised extract was then centrifuged at 20 000 g for 30 minutes. The super natant was dialysed against distilled water for 24 hours, then against 0.01 mol/l Tris HCI pH 8 for 48 hours. The resulting corneal epithelial extract was used as the sub strate in the immunoblotting assay. Tissue extracts from bovine liver, kidney and oesophagus were prepared, using the same method, and also used for immunoblotting. ). The strips were allowed to develop until a brown precipitate indicated where antibody had bound to the protein. The reaction was stopped by washing the nitrocellulose in dis tilled water to remove the substrate. One patient's serum (NC) was included as a positive standard each time in order to maintain consistency between assays. Protein bands were numbered by reference to equivalent bands on an SDS gel stained for total protein, the lowest molecular weight band being band I, approximately 29 kDa, and the highest molecular weight band being number 12, approxi mately 180 kDa.
Purification of the 54 kDa Protein
In order to purify the 54 kDa protein, the corneal extract in 0.05 mol/l NaCl, 20 mmol/l TrislHCI pH 7. 8 was loaded onto a 16 x 1.5 cm DEAE Sephacel column (Pharmacia Ltd), and eluted in 2 ml fractions. After elution of the first peak, other protein peaks were eluted using 20 mmol/l TrislHCI (pH 7. 8), containing 0.08 mol/l NaCI, 0. 3 mol/l NaCI and 1 mol/l NaCI in succession. The protein eluted by 0.08 mol/l NaCl 20 mmol/l TrislHCI (pH 7. 8) was pre dominantly the 54 kDa protein. This solution was dia lysed against 20 mmol/l Tris for 48 hours, and then stored at -20°C in aliquots until required. The 54 kDa protein ran as a single band when 6 I1g of protein were loaded onto an SDS-polyacrylamide gel. This 54 kDa protein was used in the enzyme-linked immunosorbent assay (ELISA) and the immunoblotting assay. 
RESULTS
Detection of Antibodies to Corneal Antigens by Immunofluorescence
Antibodies to the corneal epithelium were demonstrated by indirect immunofluorescence in the majority of patients with PUK (91.3%, 21/23), (Fig. la) . Of these patients, all those who also had RA (11/11) or WG (6/6) and 66% (4/6) of the remaining patients with PUK had antibodies directed against the corneal epithelium. The incidence of these antibodies in the systemic disease con trol groups without PUK was 23% (4/17) for patients with RA, 50% (4/8) for patients with WG and 10% (3/30) in the blood bank sera control group. The staining of the corneal epithelium could be divided into two quite distinct patterns (Fig. 2) : a diffuse stain covering the entire surface of the epithelium and a second 'lattice' -like pattern appearing to stain intercellular or membrane antigens. The lattice pattern was not restricted to the corneal epithelium but could be seen along the entire ocular surface including the corneal, limbal and conjunc tival epithelia. The sera of some patients produced both types of staining pattern. Thirty-nine per cent (9/23) of patients with PUK were positive for both patterns and only 4% (1/25) of patients without PUK were positive for both patterns. Neither pattern was specifically related to any particular disease group (Fig. 1 b) . Both staining patterns were reproducible on human and rat corneal epithelium.
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No antibodies could be detected in patients' sera against epithelium from bovine skin, oesophagus or intestine using the above technique.
The predominant class of antibody staining the corneal epithelium was IgG, with IgA antibodies being present in only 3 patients, all of whom had WG and PUK.
Detection of Antibodies to the Cornea by Immunoblotting
Using the soluble corneal epithelial extract separated by SDS-PAGE as a substrate, a number of putative antigens were identified using patients' sera (Fig. 3) . The number of protein bands to which serum antibodies bound varied considerably both within and between the different patient groups. The sera from 39% (9/23) of patients with PUK bound to three or more bands and of these 9 patients, 5 had both immunofluorescent staining patterns. Only 9% (2/ 21) of serum samples from patients without PUK, tested in the immunoblotting assay, bound to three or more bands (Table II) .
No band was found to be specific for a single diagnosis. of activity of disease (Table III) . Band 11 appeared to be present only in the corneal extract and it had an approxi mate molecular weight of 70 kDa. Antibodies to band 9, 54 kDa protein or BCP54, a protein specific to the cornea, occurred in 39% (9/23) of patients with corneal melt, and only 9% (2/21) of patients without ocular complications tested in the assay. Of serum samples. from patients with RA 37.5% (9/24) were positive for bands 7 and 8 (Table  III) . Proteins of a similar molecular weight to bands 7 and 8 (approximately 50 and 53 kDa) were also detected by antibodies from patients' sera in other tissue extracts, demonstrating that they are not specific to the cornea.
Detection of Antibodies to the 54 kDa Protein by
ELISA
The patients' sera were tested using ELISA for IgG, IgM or IgA antibodies to the 54 kDa protein. Thirty-five per cent (8/23) of patients with PUK had IgG antibody levels above the upper limit of normal to the 54 kDa protein, compared with only 8% (2/22) of patients with systemic disease but without ocular complications tested by ELISA (Fig. 4) . Antibodies to the 54 kDa protein occurred in the serum of some patients with PUK in isolation or in associ ation with RA or WG, demonstrating that these antibodies were not restricted to any particular disease. No patients had IgM or IgA antibodies to the 54 kDa protein. patients suggests that the diffuse staining seen in immu nofluorescence is relitted to the presence of antibodies to the 54 kDa protein in some patients. The presence of the lattice pattern by immunofluorescence did not correlate either with the presence of antibodies to the 54 kDa pro tein or with antibodies to any other protein from the cor neal extract identified in the immunoblotting assay.
Comparison of immunofluorescence staining patterns with the ELISA and immunoblotting results in individual
Detection of Antibodies to Corneal Antigens During the Course of Disease Using Serial Samples
Thirty-one sequential serum samples were available from one patient, CR, with severe WG and PUK, who required aggressive immunosuppressive therapy. These sera were tested by immunofluorescence, immunoblotting and ELISA to the 54 kDa protein. The first sample taken during the first episode of PUK was positive for the lattice pattern but negative in the ELISA for antibodies to the 54 kDa protein (Fig. 5) . The lattice pattern became undetectable upon resolution of the PUK. However, anti bodies to the 54 kDa protein as measured by ELISA did not become elevated until 7 months after the onset of melt, at which time the condition was quiescent. Serial samples from 16 other patients were also investi gated for fluctuations in antibody levels during the course of the disease. Nine were WG patients and 4 of these also had an episode of PUK; the other 7 were RA patients of whom 4 also had an episode of PUK. In 3 patients with WG and PUK, serum samples taken later in the course of disease or after resolution of the PUK were negative for the 'lattice' pattern, whereas earlier samples had been positive. Band 9, the 54 kDa protein, was the only protein to which patients' antibody levels fluctuated in the immu- noblotting assay; the same results were also seen when antibodies to the 54 kDa protein were measured by ELISA. In 4 patients, including patient CR, antibodies to the 54 kDa protein were undetectable at the outset of the PUK but in all cases became detectable later. In one patient with WG but no apparent ocular symptoms, anti bodies to the 54 kDa protein fluctuated over a period of 3 years.
DISCUSSION
Antibodies directed against the corneal epithelium were found in 91.3% of patients with PUK compared with 36% of patients without PUK and only 10% of control sera, suggesting that corneal antibodies detected by immuno fluorescence were related to the ocular rather than the systemic condition. The two distinct immunofluorescent patterns seen suggest at least two antigens were targeted by antibodies, whilst immunoblotting to a corneal epi thelial extract showed that antibodies to a larger number of antigens occurred. Corneal antibodies are not, however, restricted to patients with PUK. Circulating antibodies to the cornea have been detected in sera from patients with uveitis, Fuchs' heterochromic cyclitis and also in other systemic disease such as Beh�et's disease in which the cornea is not typically involved (La Hey,!9 Kong20 and personal obser vations). Also in this study 36% of patients with systemic disease without any ocular complications had circulating antibodies to the cornea, suggesting that the presence of antibodies alone is insufficient to cause corneal disease. It may be that accessibility of the antigens to the immune system is important, as it has been shown in the rat that although antibody production may be easily triggered, the antibodies do not reach a healthy cornea?! Table III . Number of patients in each group with antibodies to individual protein bands in the corneal epithelial extract Band no. The four most frequently detected bands are emboldened. Antibodies to bands 7 and 8 occurred in 9/24 RA patients, to Band 9 in 9/22 PUK patients, and to Band II in 8/14 WG patients. " Number of patients. 
.... Patients with systemic disease may have antibodies which bind to tissue components which cross-react with antigens in the cornea. Indeed some of these antigens are not corneal specific as antibodies bound to similar anti gens in other tissue extracts in the immunoblotting assay. Fluorescence staining, however, was only seen in corneal sections. This may be due to the different sensitivities of the immunoblotting and fluorescence assays or the fact that different antigens were detected by the two techniques.
One corneal-specific antigen, the soluble 54 kDa pro tein, has previously been described as an autoantigen in corneal disease.8 The 54 kDa protein is the most abundant soluble protein in the cornea, constituting 30% of the solu ble proteins.15 From amino acid sequencing and cDNA studies the protein shows a high sequence homology with a rat tumour-associated aldehyde dehydrogenase (RATALD).22,23 The protein has also been identified bio chemically as an aldehyde dehydrogenase in bovine and human cornea and both structural and enzymic roles have been suggested?3-25 Abedina et al. proposed a protective role for the cornea, via oxidation of aldehydes generated by light-induced lipid peroxidation, and the direct absorp tion of UV-B light by the enzyme.24 In our study anti bodies from 35% of patients with PUK bound to the 54 kDa protein by both immunoblotting and ELISA com pared with 8% of patients with systemic disease only. A similar incidence of immunity to the 54 kDa protein in patients with corneal melt was described by Kruit et al.
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who also described both humoral and cellular responses to this antigen. 8 Autoimmunity to the 54 kDa protein has also been described in other conditions: 71 % of Fuch' s heterochro mic cyclitis patients had a positive cellular response to the 54 kDa protein, but with only one third of patients having both cellular and humoral immunity.26 Immunity to the 54 kDa protein has also been described in corneal trans plantation recipients, where the authors concluded that an anti-corneal response may be a result of an intraocular inflammatory response in those patients. 13 The antibody status of a patient based on a single time point sample, however, may not reflect the true situation over a period of time. In 5 of our patients with elevated levels to the 54 kDa antigen, serial samples were available and antibody levels fluctuated in all 5. Four of these patients had at least one episode of PUK in combination with either WG or RA In all these patients antibodies to the 54 kDa antigen only became detectable after the epi sode of PUK, when the eye had become quiescent. This information supports the hypothesis that antibodies to the 54 kDa protein are produced as a response to tissue dam age in the cornea brought about by the disease process, and that they do not play any role in the initiation of the condition.
Nevertheless if an autoimmune response to the 54 kDa protein plays no role in the initiation of the ocular con dition, an immune response initiated as a result of ocular inflammation to an enzyme with an important protective role may have a pathogenic role in the disease process.
Antibodies to corneal antigens were detected which appeared to be associated more with a systemic disease rather than the ocular condition. In the systemic disease groups, 37.5% of patients with RA were positive to bands 7 and 8 in the immunoblotting assay and 57% of patients with WG were positive to band 11, irrespective of whether or not ocular manifestations were present. Bands 7 and 8 appeared to occur in other tissues and therefore antibodies may be cross-reacting with antigens in both ocular and other tissues. Band 11 (70 kDa) was not detected by anti bodies in any of the other tissues tested, suggesting it may be corneal-specific, but the nature of this antigen is at pres ent unknown. The detection of a lattice pattern by immunofluores cence was related to patients with PUK and particularly with WG (100%). The lattice pattern was present at the onset of disease in all the patients with WG and PUK and in 50% of cases the staining was lost upon remission of the PUK. The antibodies responsible for the lattice pattern may, therefore, be important in the initiation of the path ological processes. There was no correlation between any antigen identified by the immunoblotting assay and the presence of the lattice pattern. The nature of these antigens is at present unknown, but from the location of the flu orescent staining the antigen may be an insoluble mem brane protein which would not have been isolated in the extraction procedure used so far in our investigation.
The onset of PUK tends to occur at different stages of the two diseases. In the patients with WG, the ocular con dition was often a presenting problem which was impor tant in the diagnosis of the systemic disease. The patients with RA all had the diagnosis of RA for between 10 and 15 years before the onset of PUK. It is of interest, therefore, that differences are seen between the two systemic disease groups.
From this work it has become clear that antibodies in these patients are directed against a large number of cor neal antigens and some of these antibodies may be impor tant in the pathogenesis of ocular disease. We have shown that antibodies to some corneal antigens are related to the systemic rather than ocular condition. In our patients, anti bodies to the 54 kDa protein occur after ocular tissue dam age and probably play no role in the initiation of PUK. The presence of the immunofluorescent 'lattice' pattern, how ever, is more strongly related to the onset of PUK in patients with WG, and these antibodies may be a prog nostic marker for corneal disease and may be involved in the pathogenesis. In order to elucidate the role of these antibodies further it will be necessary to learn more of the nature of the antigens involved.
